PARAMETRIC PORTFOLIO ASSOCIATES LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 137 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.9%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$108,000
-67.5%
51,724
-38.7%
0.00%
Q4 2021$332,000
-12.4%
84,335
+7.0%
0.00%
Q3 2021$379,000
-3.8%
78,798
-8.2%
0.00%
Q2 2021$394,000
-27.6%
85,846
-7.4%
0.00%
Q1 2021$544,000
+64.4%
92,701
-4.3%
0.00%
Q4 2020$331,000
+324.4%
96,908
+77.9%
0.00%
Q3 2020$78,000
-23.5%
54,484
+6.8%
0.00%
Q2 2020$102,000
-8.1%
51,018
-10.7%
0.00%
Q1 2020$111,000
+22.0%
57,138
+159.4%
0.00%
Q4 2019$91,000
+111.6%
22,030
+55.2%
0.00%
Q3 2019$43,000
-50.0%
14,197
+3.5%
0.00%
Q2 2019$86,000
-12.2%
13,719
-22.0%
0.00%
Q1 2019$98,000
-21.0%
17,595
-5.4%
0.00%
Q4 2018$124,000
-88.1%
18,605
-80.9%
0.00%
-100.0%
Q3 2018$1,041,000
-19.3%
97,556
-9.2%
0.00%0.0%
Q2 2018$1,290,000
+100.6%
107,470
+43.3%
0.00%0.0%
Q1 2018$643,000
+61.6%
74,995
+86.2%
0.00%
Q4 2017$398,000
+118.7%
40,285
+264.0%
0.00%
Q2 2017$182,000
+21.3%
11,066
+2.1%
0.00%
Q4 2016$150,000
-88.8%
10,840
-88.3%
0.00%
-100.0%
Q2 2016$1,335,000
+22.7%
93,039
+2.2%
0.00%0.0%
Q1 2016$1,088,000
+551.5%
91,015
+626.1%
0.00%
Q4 2015$167,000
-7.7%
12,535
-25.5%
0.00%
Q3 2015$181,00016,8160.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$62,009,000100.00%
Artal Group S.A. 57,517,977$825,383,00017.04%
NEA Management Company, LLC 2,382,286$34,186,0001.77%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$512,0001.49%
BRIDGER MANAGEMENT, LLC 1,029,926$14,779,0000.95%
FALCON POINT CAPITAL, LLC 287,809$4,130,0000.71%
HANCOCK WHITNEY CORP 664,025$9,529,0000.40%
KINGDON CAPITAL MANAGEMENT, L.L.C. 494,380$7,094,0000.39%
ELLINGTON MANAGEMENT GROUP LLC 11,700$168,0000.23%
Convergence Investment Partners, LLC 114,157$1,638,0000.22%
View complete list of LEXICON PHARMACEUTICALS INC shareholders